Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003402-29Phase 4Completed
Phase 4, randomised trial of retinyl palmitate in Vitamin A deficiency (VAD) and retinopathy of prematurity (ROP) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoints: Retinal function at 36 corrected weeks and Conjunctival health. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003402-29.